DermTech Stock Price, News & Analysis
Company Description
DermTech (NASDAQ: DMTK) is a publicly traded diagnostic imaging centers company in the Services-medical Laboratories sector. The company has a market capitalization of $3.3M, ranking #6,849 among all listed U.S. companies by market cap.
DMTK stock has declined 98.2% over the past year. Shares last traded at $0.0940.
This page provides a comprehensive overview of DMTK stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
DermTech (DMTK) stock last traded at $0.0940. Over the past 12 months, the stock has lost 98.2%. At a market capitalization of $3.3M, DMTK is classified as a micro-cap stock with approximately 35.0M shares outstanding.
Latest News
DermTech has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 7 with negative movement. Key topics include earnings, clinical trial. View all DMTK news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
DMTK Company Profile & Sector Positioning
DermTech (DMTK) operates in the Diagnostic Imaging Centers industry within the broader Services-medical Laboratories sector and is listed on the NASDAQ.